Synthesis and antihypertensive activity of novel quinazolin-4(3H)-one derivatives
A series of novel substituted quinazolin-4(3H)-one derivatives were synthesized and screened in vivo for their antihypertensive activities. Out of eighteen synthesized compounds, seven i.e. 2a, 2c, 4a, 4d, 5d, 6a & 6b compounds have shown hypotensive effect and produced bradycardia. These compounds have shown better activity than reference drug Prazosin (which acts as anti-hypertensive agent by α1 blocking action). All the compounds have shown ALD50>1000mg/kg with maximum in 2c & 4d (>1200mg/kg).
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2014 |
---|---|
Erschienen: |
2014 |
Enthalten in: |
Zur Gesamtaufnahme - volume:14 |
---|---|
Enthalten in: |
Central nervous system agents in medicinal chemistry - 14(2014), 1 vom: 15., Seite 34-8 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Pathak, Seema R [VerfasserIn] |
---|
Themen: |
Antihypertensive Agents |
---|
Anmerkungen: |
Date Completed 24.07.2015 Date Revised 13.11.2019 published: Print Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM241466423 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM241466423 | ||
003 | DE-627 | ||
005 | 20231224124320.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2014 xx |||||o 00| ||eng c | ||
028 | 5 | 2 | |a pubmed24n0804.xml |
035 | |a (DE-627)NLM241466423 | ||
035 | |a (NLM)25174978 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Pathak, Seema R |e verfasserin |4 aut | |
245 | 1 | 0 | |a Synthesis and antihypertensive activity of novel quinazolin-4(3H)-one derivatives |
264 | 1 | |c 2014 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 24.07.2015 | ||
500 | |a Date Revised 13.11.2019 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a A series of novel substituted quinazolin-4(3H)-one derivatives were synthesized and screened in vivo for their antihypertensive activities. Out of eighteen synthesized compounds, seven i.e. 2a, 2c, 4a, 4d, 5d, 6a & 6b compounds have shown hypotensive effect and produced bradycardia. These compounds have shown better activity than reference drug Prazosin (which acts as anti-hypertensive agent by α1 blocking action). All the compounds have shown ALD50>1000mg/kg with maximum in 2c & 4d (>1200mg/kg) | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a Antihypertensive Agents |2 NLM | |
650 | 7 | |a Quinazolines |2 NLM | |
700 | 1 | |a Malhotra, Vineet |e verfasserin |4 aut | |
700 | 1 | |a Nath, Rajendra |e verfasserin |4 aut | |
700 | 1 | |a Shanker, Kripa |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Central nervous system agents in medicinal chemistry |d 2008 |g 14(2014), 1 vom: 15., Seite 34-8 |w (DE-627)NLM185149960 |x 1875-6166 |7 nnns |
773 | 1 | 8 | |g volume:14 |g year:2014 |g number:1 |g day:15 |g pages:34-8 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 14 |j 2014 |e 1 |b 15 |h 34-8 |